Weiss L, Stintzing S, Modest DP, Stahler A, et al. First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF(V600E)-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC ( Eur J Cancer 2025;232:116105.
PMID: 41240527